A new report commissioned by the private health insurance (PHI) industry states medical devices used in surgery in Australia cost...
Read moreIn September 2023, the doors will open on the largest optometric event in the region when O=MEGA23 combines with the...
Read moreProminent UK ophthalmologist Professor Pearse Keane – considered a global leader in ophthalmic artificial intelligence (AI) advances – will headline...
Read moreGlaukos has entered into a collaboration and marketing agreement with Radius XR, seeing Glaukos become the exclusive sales agent to...
Read moreAre you a solutions provider attending the RANZCO Congress in Perth later this year? Does your business offer Dry Eye...
Read moreClinical stage biopharmaceutical company Opthea, based in Melbourne, has adopted the non-proprietary drug name “sozinibercept” for its lead drug candidate,...
Read moreThree surgeons provide a bird’s eye view on the current state of cataract surgery in Australia, including equity and accessibility...
Read moreIf you’re in the business of myopia management, then Insight’s September issue is an ideal opportunity to present your product...
Read moreAt the completion of this article, the reader should be able to improve their management of patients with traumatic brain...
Read moreO=MEGA23 is on the horizon and the industry is once again buzzing in anticipation. Australia’s biggest eyecare and eyewear fair...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited